Ftse Mib
32.902,31
-0,80%
DAX
19.226,24
-0,41%
S&P 500
6.021,63
0,57%
NASDAQ
19.175,58
0,63%
Bitcoin
93.405,01
1,57%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Unicycive Therapeutics Inc (UNCY) Unicycive Therapeutics Inc (UNCY) Notizie

Unicycive Therapeutics Inc

UNCY
0,5901
0,00 (0,00%)
27 Nov 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
21/11/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
15/11/202401:13EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
15/11/202401:01EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
13/11/202423:29EDGAR2Form S-3 - Registration statement under Securities Act of..
13/11/202414:04EDGAR2Form 8-K - Current report
13/11/202413:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
28/10/202412:03GLOBEUnicycive Therapeutics Delivers Multiple Poster..
16/10/202422:35GLOBEUnicycive Therapeutics to Participate in a Fireside Chat at..
14/10/202413:03GLOBEUnicycive Therapeutics Announces Late-Breaker Poster..
11/10/202422:02EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
09/10/202413:03GLOBEUnicycive Therapeutics Successfully Completes UNI-494 Phase..
24/9/202413:03GLOBEUnicycive Therapeutics to Participate in a Fireside Chat at..
16/9/202413:03GLOBEUnicycive Therapeutics to Present at the Virtual Life..
05/9/202413:03GLOBEUnicycive Therapeutics to Present at the H.C. Wainwright..
03/9/202413:03GLOBEUnicycive Therapeutics Announces Submission of the New Drug..
26/8/202413:03GLOBEUnicycive Therapeutics to Present Three Posters at the..
14/8/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202414:11EDGAR2Form 8-K - Current report
14/8/202413:10GLOBEUnicycive Announces Second Quarter 2024 Financial Results..
14/8/202413:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
17/7/202413:03GLOBEUnicycive Therapeutics Granted Patent on UNI-494 to Treat..
16/7/202416:31EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
15/7/202422:15EDGAR2Form 8-K - Current report
15/7/202422:15EDGAR2Form 8-K - Current report
11/7/202413:03GLOBEUnicycive Therapeutics to Participate in Fireside Chat at..
10/7/202413:03GLOBEUnicycive Therapeutics Announces Initial Positive Patient..
01/7/202413:03GLOBEUnicycive Therapeutics Joins Russell Microcap® Index
25/6/202413:30GLOBEUnicycive Therapeutics Achieves Study Objective in..
28/5/202413:03GLOBEUnicycive Therapeutics Delivers Multiple Presentations on..
23/5/202413:03GLOBEUnicycive Therapeutics to Participate in a Fireside Chat at..
15/5/202413:03GLOBEUnicycive Therapeutics Presents Bioequivalence Data on..
13/5/202422:28EDGAR2Form 8-K - Current report
13/5/202422:16GLOBEUnicycive Announces First Quarter 2024 Financial Results and..
13/5/202422:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202422:05EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
10/4/202413:03GLOBEUnicycive Therapeutics to Present at the Noble Capital..
28/3/202421:15GLOBEUnicycive Therapeutics Announces Full Year 2023 Financial..
25/3/202412:03GLOBEUnicycive Therapeutics to be Featured in Multiple..
14/3/202412:03GLOBEUnicycive Announces $50 Million Private Placement
13/3/202412:03GLOBEUnicycive Therapeutics Delivers Both an Oral and Poster..
07/3/202422:12GLOBEUnicycive Therapeutics Completes Enrollment in Pivotal..
04/3/202413:03GLOBEUnicycive Therapeutics Announces Orphan Drug Designation..
21/2/202422:06EDGAR2Form 8-K - Current report
14/2/202413:03GLOBEUnicycive Therapeutics to Present Two Posters on..
29/1/202413:03GLOBEUnicycive Therapeutics Announces Both an Oral and Poster..
23/1/202413:03GLOBEUnicycive Therapeutics Issues Shareholder Letter to..
22/1/202422:27EDGAR2Form SC 13G - Statement of acquisition of beneficial..
18/12/202313:03GLOBEUnicycive Therapeutics Announces Enrollment of First Patient..
08/12/202322:36EDGAR2Form S-8 - Securities to be offered to employees in employee..
Apertura: Min: Max:
Chiusura: 0,5901

La tua Cronologia

NASDAQ
UNCY
Unicycive Therapeutics
BOV
A2LC34
Alcon
LSE
0LYB
Zaklady Magnezytowe Ropc...
BIT
P1QMK1
BNP Paribas Issuance
BIT
P1SW04
BNP Paribas Issuance
BOV
MAPT3F
CEMPE ON
BIT
P1T5S1
BNP Paribas Issuance
LSE
SMIF
Twentyfour Select Monthl...
USOTC
PPCB
Propanc Biopharma (PK)
TSX
HAI
Haivision Systems
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network